Orthopedic Soft Tissue Repair Market by Procedure, Injury Location, Product, End-User

Description

List of Tables

[189 Pages Report] The Orthopedic Soft Tissue Repair Market size was estimated at USD 6.19 billion in 2023 and expected to reach USD 7.08 billion in 2024, at a CAGR 15.56% to reach USD 17.04 billion by 2030.

Orthopedic soft tissue repair includes surgeries and treatments to improve joint stability by repairing the functional length of ligaments, muscles, and tendons. Soft-tissue surgeries of the lower extremity include cartilage resections or repairs, tendon transfers, muscle repairs, fasciotomies, and ligament reconstructions. The rising cases of sports-related injuries and increase in obesity rate due to changing lifestyles and food consumption patterns are resulting in an increased risk of soft tissue damage among the population. Sprains, strains, contusions, tendinitis, and bursitis are common orthopedic soft-tissue injuries. The potential suitability of additive manufacturing technology for soft tissue regeneration can aid in efficiently repairing damaged soft tissues. However, high cost and translational challenges associated with soft tissue regeneration may refrain patients from attaining orthopedic soft tissue repair surgeries and treatments. Moreover, the introduction of novel surgical techniques along with applications of orthobiologics is expected to improve the treatment outcomes for orthopedic soft tissue repair surgeries.

KEY MARKET STATISTICS
Base Year [2023]	USD 6.19 billion
Estimated Year [2024]	USD 7.08 billion
Forecast Year [2030]	USD 17.04 billion
CAGR (%)	15.56%

Procedure: suitability of epicondylitis procedures in relieving pain and restoring function in the elbow

Achilles tendinosis repair procedure involves the surgical repair of the Achilles tendon, typically due to degenerative wear or injury. It often incorporates debridement (removal) of damaged tissue, sometimes combined with tendon transfer or augmentation techniques to improve functionality and reduce pain. Anterior Cruciate Ligament (ACL) Repair is a surgical intervention to reconstruct the torn anterior cruciate ligament in the knee. It usually involves using a graft taken from another tendon around the knee or from a donor to replace the damaged ACL, thereby restoring knee stability and function. The Biceps Tenodesis procedure is implemented to treat shoulder pain often associated with biceps tendon pathology. Biceps tenodesis involves surgically anchoring the biceps tendon to the upper part of the humerus, thereby alleviating stress on the tendon and reducing pain or discomfort. Cruciate Ligaments Repair refers to the surgical treatment of torn ligaments in the knee (both anterior and posterior cruciate ligaments); this procedure aims to restore stability and function. Surgeons may opt for reconstruction using grafts or primary repair, depending on the injury's nature and the patient's specific needs.

Epicondylitis (Golfer's or Tennis Elbow) Treatment focuses on relieving pain and restoring function in the elbow caused by overuse of the forearm muscles. Non-surgical and surgical options exist, with surgery typically being reserved for cases that do not respond to conservative treatments. Gluteal Tendon Repair addresses tears or damage in the gluteal tendons, which are critical for hip stability and function. Surgical repair involves suturing the torn tendon back to its normal attachment site, sometimes incorporating grafts or augmentation devices. Hip Arthroscopy represents a minimally invasive surgical procedure that enables doctors to investigate hip joint without large incision through the skin & other soft tissues. It's often used to diagnose and treat several hip problems, including removal of loose fragments, debridement of damaged tissue, and repair of torn labrums. Rotator cuff repair involves reattachment of the torn rotator cuff tendon(s) to the humerus. The procedure can be operated through traditional open surgery, minimally invasive arthroscopy, or a combination of the two, aimed at improving shoulder strength and function while reducing pain.

End User: High dominance of hospitals setting for orthopedic soft tissue repair procedures

Hospitals remain the largest and most traditional setting for orthopedic soft tissue repair procedures. Their capacity to handle various surgeries, including high-acuity cases, makes them a critical component of the healthcare ecosystem. Hospitals are characterized by their comprehensive care, including pre-surgery consultations, a broad spectrum of surgical options, and extensive post-operative rehabilitation services. The integration of multi-disciplinary teams and access to advanced medical technology further underline the importance of hospitals. However, the high overhead costs and longer patient stays are challenges that hospitals continuously seek to optimize. Orthopedic Clinics specialize in diagnosing, treating, and managing musculoskeletal system disorders, including soft tissue injuries. These clinics offer a focused approach to orthopedics, providing expert consultations, non-surgical treatment options, and minor surgical procedures in a more personal and less congested setting compared to hospitals. The personalized care, coupled with the quick scheduling of appointments and procedures, makes orthopedic clinics a preferred choice for patients seeking convenience and highly specialized care. The close collaboration with rehabilitation services ensures a holistic approach to patient recovery and care continuity.

Ambulatory Surgical Centers (ASCs) have emerged as a preferred setting for orthopedic soft tissue repair procedures, primarily due to their cost-effectiveness and efficiency. The streamlined operational models of ASCs allow for shorter wait times and a focus on patient convenience and satisfaction. Additionally, ASCs often utilize the latest technological advancements and minimally invasive techniques, which promote faster recovery times and reduce postoperative complications.

Regional Insights

The orthopedic soft tissue regeneration market is evolving in the Americas due to the increasing tendon and ligament injuries, growing obese population, and rising approvals for soft tissue repair treatments. Significant incidences of age-related orthopedic disorders, including damage to soft tissues, necessitate enhanced and improved soft tissue repair treatments in the APAC region. Sports and obesity-related soft tissue injuries and improving orthopedic healthcare infrastructure contribute to the expansion of the APAC's orthopedic soft tissue repair market. The EMEA region represents a highly evolving orthopedic soft tissue repair market due to the growing need for efficient treatment for accidental injuries, the increase in orthopedic soft tissue repair treatment approvals, and the rising availability of novel solutions for soft tissue repair. Additionally, ongoing research and the introduction of breakthrough technologies for treating soft tissue damage are expected to create immense potential for the growth of the orthopedic soft tissue repair market worldwide.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Orthopedic Soft Tissue Repair Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Orthopedic Soft Tissue Repair Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Orthopedic Soft Tissue Repair Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Acera Surgical Inc., Acumed, LLC, Amnio ReGen Solutions, Anika Therapeutics, Inc., Aroa Biosurgery Limited, Arthrex, Inc., B. Braun SE, Baxter International, Inc., Becton, Dickinson and Company, Bioventus Inc., CollPlant Biotechnologies Ltd., CoNextions Inc., CONMED Corporation, Dunamis Medical, LLC, Geistlich Pharma AG, Integra Lifesciences Holdings Corporation, Isto Biologics, Johnson & Johnson Services, Inc., Karl Storz SE & Co. KG, Maruho Medical, Inc., Medartis AG, Medtronic PLC, Mesh Suture, Inc., Novadip Biosciences S.A., Organogenesis Inc., Smith & Nephew PLC, Stryker Corporation, Teleflex Inc., Tissue Regenix Group PLC, Xiros Ltd., Zimmer Biomet Holdings, Inc., and ZimVie Inc..

Market Segmentation & Coverage

This research report categorizes the Orthopedic Soft Tissue Repair Market to forecast the revenues and analyze trends in each of the following sub-markets:

Procedure
- Achilles Tendinosis Repair
- Anterior Cruciate Ligament
- Biceps Tenodesis
- Cruciate Ligaments Repair
- Epicondylitis
- Gluteal Tendon Repair
- Hip Arthroscopy
- Rotator Cuff Repair

Injury Location
- Hip
- Knee
- Shoulder
- Small Joints

Product
- Fixation Devices
  - Interference Screws
  - Suture Anchors
  - Transosseous Tunnels

Tissue Patch

End-User
- Ambulatory Centers
- Hospitals
- Orthopedic Clinics

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam

Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Orthopedic Soft Tissue Repair Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Orthopedic Soft Tissue Repair Market?

3. What are the technology trends and regulatory frameworks in the Orthopedic Soft Tissue Repair Market?

4. What is the market share of the leading vendors in the Orthopedic Soft Tissue Repair Market?

5. Which modes and strategic moves are suitable for entering the Orthopedic Soft Tissue Repair Market?

Product Code: MRR-ED54C46E8E67

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Rising incidences of sports-related injuries worldwide
  - 5.1.1.2. Growing aging population and obesity rate
  - 5.1.1.3. Emerging utilization of 3D printing for orthopedic soft tissue regeneration
- 5.1.2. Restraints
  - 5.1.2.1. High cost of orthopedic surgical procedures
- 5.1.3. Opportunities
  - 5.1.3.1. Emerging innovative surgical techniques for soft tissue regeneration and orthobiologics in orthopedics
  - 5.1.3.2. Rising approvals for novel soft tissue repair regenerative technologies
- 5.1.4. Challenges
  - 5.1.4.1. Translational challenges in soft tissue regeneration
5.2. Market Segmentation Analysis
- 5.2.1. Procedure: suitability of epicondylitis procedures in relieving pain and restoring function in the elbow
- 5.2.2. End User: High dominance of hospitals setting for orthopedic soft tissue repair procedures
5.3. Market Trend Analysis
- 5.3.1. Expansion of the orthopedic soft tissue repair market in the Americas owing to the rising occurrence of sports injuries and the number of FDA approvals
- 5.3.2. Initiatives and investments to improve the healthcare infrastructure in the APAC region
- 5.3.3. The rising burden of sports and accidental injuries creating the need for orthopedic soft tissue repair products in the EMEA region
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter's Five Forces Analysis
- 5.6.1. Threat of New Entrants
- 5.6.2. Threat of Substitutes
- 5.6.3. Bargaining Power of Customers
- 5.6.4. Bargaining Power of Suppliers
- 5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework Analysis
5.9. Client Customization

6. Orthopedic Soft Tissue Repair Market, by Procedure

6.1. Introduction
6.2. Achilles Tendinosis Repair
6.3. Anterior Cruciate Ligament
6.4. Biceps Tenodesis
6.5. Cruciate Ligaments Repair
6.6. Epicondylitis
6.7. Gluteal Tendon Repair
6.8. Hip Arthroscopy
6.9. Rotator Cuff Repair

7. Orthopedic Soft Tissue Repair Market, by Injury Location

7.1. Introduction
7.2. Hip
7.3. Knee
7.4. Shoulder
7.5. Small Joints

8. Orthopedic Soft Tissue Repair Market, by Product

8.1. Introduction
8.2. Fixation Devices
8.3. Tissue Patch

9. Orthopedic Soft Tissue Repair Market, by End-User

9.1. Introduction
9.2. Ambulatory Centers
9.3. Hospitals
9.4. Orthopedic Clinics

10. Americas Orthopedic Soft Tissue Repair Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Orthopedic Soft Tissue Repair Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Orthopedic Soft Tissue Repair Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
- 13.3.1. Enovis Continues Expansion of Foot & Ankle Portfolio with Knotless Syndesmotic Repair System
- 13.3.2. Smith+Nephew unveils 'Precision in Motion' for its Orthopaedics Arthroplasty portfolio at AAOS 2023 Annual Meeting
- 13.3.3. Arthrex Receives FDA Clearance for TightRope Implant as First, Only Device Cleared for Pediatric ACL Surgery
- 13.3.4. Zimmer Biomet planned to acquire the soft tissue healing company Embody
- 13.3.5. Stryker launched new product for foot, ankle surgeries
- 13.3.6. Novadip Biosciences Raises Additional EUR 40 Million Bringing Total Company Funding to EUR 88 Million
- 13.3.7. Medartis and Field Orthopaedics Partner to Expand Offerings
- 13.3.8. MSi's DURAMESH Earns FDA Nod For Soft Tissue Closure
- 13.3.9. CONMED (CNMD) Acquires Soft Tissue Implant Start-Up Biorez
- 13.3.10. OREF and OTA Extend Collaboration with New Soft Tissue Injury Research Grant and Funding Support from Arthrex, Inc.
- 13.3.11. Orthocell Signed Striate+ Exclusive License & Agreement with BioHorizons

14. Competitive Portfolio

14.1. Key Company Profiles
14.2. Key Product Portfolio